Aptose Biosciences has a total of 161 patents globally, out of which 69 have been granted. Of these 161 patents, more than 37% patents are active. The United States of America is where Aptose Biosciences has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Aptose Biosciences.
Aptose Biosciences was founded in the year 1986. The Company operates as pharmaceutical company and focuses on the development of cancer therapies and treatment of pancreatic cancer.
Do read about some of the most popular patents of Aptose Biosciences which have been covered by us in this article and also you can find Aptose Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aptose Biosciences patent portfolio.
How many patents does Aptose Biosciences have?
Aptose Biosciences has a total of 161 patents globally. These patents belong to 36 unique patent families. Out of 161 patents, 60 patents are active.
How Many Patents did Aptose Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Aptose Biosciences Applications Filed | Aptose Biosciences Patents Granted |
2023 | – | 2 |
2022 | 6 | 2 |
2021 | 10 | 10 |
2020 | 7 | 2 |
2019 | 12 | 4 |
2018 | 21 | 2 |
2017 | 8 | 3 |
2016 | 3 | 2 |
2015 | 2 | 3 |
2014 | 21 | 2 |
2013 | 1 | 1 |
2012 | – | 2 |
2011 | – | 2 |
How many Aptose Biosciences patents are Alive/Dead?
Worldwide Patents
How Many Patents did Aptose Biosciences File in Different Countries?
Countries in which Aptose Biosciences Filed Patents
Country | Patents |
United States Of America | 37 |
Europe | 18 |
Japan | 14 |
Austria | 9 |
Germany | 8 |
Australia | 7 |
Spain | 7 |
Hong Kong (S.A.R.) | 7 |
China | 6 |
Korea (South) | 6 |
New Zealand | 5 |
Canada | 4 |
Mexico | 3 |
Israel | 3 |
Taiwan | 2 |
Denmark | 2 |
Singapore | 1 |
India | 1 |
Russia | 1 |
Argentina | 1 |
Norway | 1 |
Macao | 1 |
Where are Research Centers of Aptose Biosciences Patents Located?
10 Best Aptose Biosciences Patents
WO2006017932A1 is the most popular patent in the Aptose Biosciences portfolio. It has received 23 citations so far from companies like Novartis Ag, and Arrowhead Pharmaceuticals.
Below is the list of 10 most cited patents of Aptose Biosciences:
Publication Number | Citation Count |
WO2006017932A1 | 23 |
US8148392B2 | 21 |
WO2018098561A1 | 18 |
WO2004104197A1 | 17 |
WO2005065719A1 | 15 |
US6593305B1 | 11 |
US7884120B2 | 11 |
US8394815B2 | 8 |
US8969372B2 | 8 |
US10921240B1 | 6 |
What Percentage of Aptose Biosciences US Patent Applications were Granted?
Aptose Biosciences (Excluding its subsidiaries) has filed 20 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 14 have been granted leading to a grant rate of 82.3%.
Below are the key stats of Aptose Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Aptose Biosciences?
Law Firm | Total Applications | Success Rate |
Cooley Llp | 20 | 82.35% |
What are Aptose Biosciences key innovation segments?
What Technologies are Covered by Aptose Biosciences?
The chart below distributes patents filed by Aptose Biosciences